FORM OF WARRANTVitro Biopharma, Inc. • November 22nd, 2023 • Biological products, (no disgnostic substances)
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 22nd, 2023 • Vitro Biopharma, Inc. • Biological products, (no disgnostic substances) • Arizona
This Securities Purchase Agreement (this “Agreement”) is dated as of November 16, 2023 between Vitro Biopharma, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the Annex A hereto (each, including its successors and assigns, an “Investor” or “Holder”) and collectively, the “Investors”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 22nd, 2023 • Vitro Biopharma, Inc. • Biological products, (no disgnostic substances)
This Registration Rights Agreement (this “Agreement”) is made and entered into as of November 16, 2023, between Vitro Biopharma, Inc., a Nevada corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” or “Holder” and, collectively, the “Purchasers”).
FORM OF SECURITY AGREEMENTForm of Security Agreement • November 22nd, 2023 • Vitro Biopharma, Inc. • Biological products, (no disgnostic substances)
This SECURITY AGREEMENT, dated as of November 16, 2023 (this “Agreement”), is among Vitro Biopharma, Inc., a Nevada corporation ( “Debtor”), on the one hand, and the holder(s) of the Company’s 20% original issue discount senior secured convertible notes in the aggregate original principal amount of up to $3,000,000.00 (collectively, the “Notes”) signatory hereto, their endorsees, transferees and assigns (each holder a “Secured Party,” and collectively, the “Secured Parties”), on the other. Each of the Company and the Secured Parties are a “party” to this Agreement, and one or more of them are the “parties” hereto as the context may require.
CONSULTING AGREEMENTConsulting Agreement • November 22nd, 2023 • Vitro Biopharma, Inc. • Biological products, (no disgnostic substances) • New York
This Consulting Agreement (this “Agreement”) is entered into as of this 16th day of November, 2023 (the “Effective Date”), by and between (1) Alchemy Advisory LLC, a limited liability company organized under the laws of Puerto Rico (the “Consultant”) and located at , and (2) Vitro Biopharma, Inc., a Nevada corporation (the “Company”) and having its principal place of business at 3200 Cherry Creek Drive South, Suite 720, Denver, Colorado 80209. The Company and Consultant are collectively referred to herein as the “Parties”.
